The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Dr Ducu Botoaca, who has a central London aesthetics clinic, told the MailOnline that he has seen a worrying increase in ...

New research reveals weight is swiftly regained after discontinuing anti-obesity medications like Ozempic, despite their ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

The healthcare worker warns that most people will put two thirds of the weight back on within a year of coming off the ...